Recombinant in Biological Technology

PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

... SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine ... nerve agents RypVax(TM) - a recombinant dual antigen vaccine for plague For ... the HHS Request for Proposals for an Anthrax recombinant Protective Antigen (rPA) Vaccine for the ...

Inspiration Biopharmaceuticals Presents Safety Data on IB1001, a Novel Recombinant Factor IX for the Treatment of Hemophilia at the International Society on Thrombosis and Haemostasis (ISTH) Annual Meeting

... data on its lead product, IB1001, a novel recombinant Factor IX product to treat patients with ... About IB1001 IB1001 is an intravenous recombinant Factor IX product for the acute and preventative ... IB1001 is produced with Inspiration's proprietary recombinant protein manufacturing technology, which ...

PharmAthene's 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review

... for SparVax(TM), PharmAthene's next generation recombinant protective antigen (rPA) anthrax vaccine. In ... SparVax(TM) is a novel second generation recombinant protective (rPA) anthrax vaccine being developed ... SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine ...

Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa

... follicle stimulants, achieved similar efficacy to recombinant follicle stimulating hormone (rFSH) given once ... pregnancy rates with corifollitropin alfa and recombinant FSH irrespective of variations in ART procedures. ... Behr B, et al Corifollitropin alfa versus recombinant FSH treatment in controlled ovarian stimulation: ...

Commercial Manufacturing of H1N1 'Swine Flu' Vaccine Underway

... vaccines and biopharmaceuticals. PSC uses recombinant DNA technology to make novel human and veterinary ... ingredients in all of the firm's products are recombinant proteins that are manufactured, using its ... PSC's lead product is FluBlok(R), a seasonal recombinant trivalent influenza vaccine consisting of ...

PharmAthene Reports First Quarter 2009 Financial and Operational Results

... SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine ... to chemical nerve agents RypVax(TM) - a recombinant dual antigen vaccine for plague ... the DHHS Request for Proposals for an Anthrax recombinant Protective Antigen (rPA) Vaccine for the ...

Recombinant C-Reactive Protein

... its C-Reactive Protein product line to include recombinant C-Reactive Protein. C-Reactive Protein is a ... r-hCRP is produced into culture medium by DNA recombinant procedure in E. Coli as secretory protein. By ... membrane of E. Coli becomes permeable, allowing recombinant C-Reactive Protein to be excreted without cell ...

Protein Sciences Announces Signing of a Forbearance Agreement With Emergent BioSolutions

... vaccines and biopharmaceuticals. PSC uses recombinant DNA technology to make novel human and veterinary ... ingredients in all of the firm's products are recombinant proteins that are manufactured, using its ... Company's lead product is FluBlok(R), a seasonal recombinant trivalent influenza vaccine, consisting of ...

PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research

... SparVax(TM) is a novel second generation recombinant protective antigen (rPA) anthrax vaccine that is ... SparVax(TM) is a novel second generation recombinant protective (rPA) anthrax vaccine being developed ... SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine ...

InVitria Reveals Technology to Optimize Hybridoma Production Performance

... but also outperform other sources of native and recombinant albumin.” To obtain a copy of the ... Growth and Productivity of a Hybridoma with recombinant Human Albumin and Lactoferrin,” please ... Growth and Productivity of a Hybridoma with recombinant Human Albumin and Lactoferrin. BioProcessing ...

NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains

... Novavax scientists designed and produced a recombinant VLP vaccine candidate against the 1918 H1N1 ... vaccine candidate created through cell-based recombinant technology has the potential to protect against ... The company produces these VLP based, potent, recombinant vaccines utilizing new, and efficient ...

SemBioSys provides update on insulin program

... an update on its proprietary plant-produced recombinant human insulin program. In December 2008, ... rights to SemBioSys' proprietary plant-produced recombinant human insulin to be used primarily for ... reported results from the Phase I/II trial of its recombinant human insulin (SBS-1000) in human volunteers. ...

PharmAthene Announces $5.5 Million Public Equity Offering

... SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine ... to chemical nerve agents RypVax(TM) - a recombinant dual antigen vaccine for plague ... the DHHS Request for Proposals for an Anthrax recombinant Protective Antigen (rPA) Vaccine for the ...

SemBioSys Genetics Inc. Announces Clinical Results with Plant-Produced Insulin

... its first "in-man" clinical study of SBS-1000, a recombinant human insulin manufactured using its proprietary ... demonstrated that SBS-1000 was bioequivalent to a recombinant human insulin with the expected safety profile. ... observed were typical for a study involving recombinant human insulins. The most common events were ...

Bone Biologics Announces UCB-1 (NELL-1) Bone Growth Protein Production Process With Aragen Biosciences

... Aragen Bioscience, has completed development of a recombinant cell line and initial production process for UCB-1 (NELL-1) recombinant protein. Bone Biologics has been developing ... in Morgan Hill, California. Aragen specializes in recombinant cell line and hybridoma development, cell culture ...

PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting

... SparVax(TM) is a novel second generation recombinant protective antigen (rPA) anthrax vaccine that is ... SparVax(TM) is a novel second generation recombinant protective (rPA) anthrax vaccine being developed ... SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine ...

DSM and Crucell Sign Agreement with Bioceros to Serve as Pre-Approved Cell Line Generation Partner of PER.C6(R) Cell Line Proteins

... manufacture of biopharmaceutical products such as recombinant proteins, including monoclonal antibodies. ... manufacture of biopharmaceutical products such as recombinant proteins including monoclonal antibodies. ... human cell line as a production platform for recombinant proteins and monoclonal antibodies. The ...

Novavax and Vivalis Sign a Research License Agreement to Use the EB66(R) Cell Line for the Production of Virus Like Particle Based Vaccines

... scalable cell culture solutions for production of recombinant VLP vaccines and increases our flexibility to ... The development of production systems for recombinant proteins and monoclonal antibodies. VIVALIS licenses its EB66(R) cell line for the production of recombinant proteins to biotechnology and pharmaceutical ...

InVitria Among Leading Innovators in Cell Culture Media According to Top Biotechnology Publication

... media components, such as InVitria's animal free recombinant media, have contributed to these improvements. Test results have confirmed that InVitria's recombinant albumin (Cellastim™) outperforms ... in CHO and hybridoma cell lines. InVitria's recombinant lactoferrin (Lacromin™) is a strong cell ...

ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4

... Novozymes Biopharma will exclusively supply its recombinant human albumin, Recombumin(R), for the continued ... Biopharma will also supply Recombumin(R) or other recombinant albumin products for the further development of ... The Exendin-4 analog is covalently bound to recombinant human albumin (Recombumin(R), provided by ...

Pharmathene Reports Third Quarter 2008 Financial and Operational Results

... -- SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine -- ... to chemical nerve agents -- RypVax(TM) - a recombinant dual antigen vaccine for plague -- a third ... the DHHS Request for Proposals for an Anthrax recombinant Protective Antigen (rPA) Vaccine for the ...

Cleveland Clinic Recognizes New Strategies for Creating Vaccines for Avian Flu as a Top Ten Medical Innovation for 2009

... manufacturing platform worldwide. VLPs are recombinant structures that mimic the size and shape of ... Because the Novavax process involves recombinant technology and does not require a live influenza ... The Company produces these VLP based, potent, recombinant vaccines utilizing new, and efficient ...

ConjuChem Provides Development Update

... The Exendin-4 analog is covalently bound to recombinant human albumin (Recombumin(R), provided by ... PC-DAC(TM) technology, PC-Insulin is a recombinant insulin that is covalently bound to recombinant human albumin (Recombumin(R), provided by ...

New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture

... and industry reveal powerful effects of recombinant lactoferrin (tradename: Lacromin) in mammalian ... Cellular & Developmental Biology revealed that recombinant lactoferrin (tradename: Lacromin, see ... coordinated the study entitled, "Bioactive recombinant human lactoferrin, derived from rice, stimulates ...

PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program

... SparVax(TM) is a novel second generation recombinant protective (rPA) anthrax vaccine consisting of ... include: -- SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine -- ... to chemical nerve agents -- RypVax(TM) - a recombinant dual antigen vaccine for plague For more ...

InVitria Touts Product Advantages at Cambridge's Cell Culture Conference

... line includes: -- Cellastim - Cellastim is a recombinant albumin that is used as a cell culture ingredient ... ) -- Lacromin - Lacromin is recombinant human lactoferrin, a growth factor that also ... compared to chicken lysozyme and provides higher recombinant protein yield compared with mechanical cell ....

Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial

... of its novel influenza VLP vaccines. VLPs are recombinant structures that mimic the size and shape of ... Novavax's influenza VLPs are produced through recombinant technology in insect cell culture, utilizing a ... Because the Novavax process involves recombinant technology and does not require a live influenza ...

PharmAthene to Present Data for Protexia(R) and Valortim(R) at HHS PHEMCE Stakeholders Workshop 2008

... VA September 24 -26, 2008. Protexia(R), a recombinant version of human butyrylcholinesterase (BChE), is ... -- SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine -- ... to chemical nerve agents -- RypVax(TM) - a recombinant dual antigen vaccine for plague For more ...

SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND

... production host for insulin. Plant-produced human recombinant insulin represents a major step forward in ... in insulin production since the advent of recombinant human insulin in the early 80's," said Andrew ... in the plant host safflower, are recombinant human insulin to serve the rapidly expanding ...

Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate

... of its novel influenza VLP vaccines. VLPs are recombinant structures that mimic the size and shape of ... Novavax's influenza VLPs are produced through recombinant technology in insect cell culture, utilizing a ... Because the Novavax process involves recombinant technology and does not require a live influenza ...

PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration

... (DHHS) that the Company's proposal for its recombinant protective antigen anthrax vaccine, SparVax(TM), ... to a Request for Proposals for an Anthrax recombinant Protective Antigen (rPA) Vaccine for the ... SparVax(TM) is a novel second generation recombinant protective antigen (rPA) anthrax vaccine being ...

Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value

... product developments include: -- The patented recombinant malaria vaccine candidate (PfCP2.9), for which ... of the Company's patented anti-bleeding agent, recombinant Batroxobin (rBAT). Should the product proceed to ... and for a Chinese patent for an innovative recombinant multivalent tuberculosis vaccine. -- Continuing ...

PharmAthene Reports Second Quarter 2008 Financial and Operational Results

... 25 million doses of a second generation recombinant protective antigen (rPA) anthrax vaccine for ... SparVax(TM), a second generation anthrax recombinant protective antigen (rPA) vaccine, as well as RypVax(TM), the Company's recombinant dual antigen plague vaccine. Research and ...

Lord Lewis Moonie to Serve as Special UK Government Advisor to PharmAthene

... at Porton Down, which included recombinant vaccines for plague and anthrax, will be ... include: -- SparVax(TM) -- a second generation recombinant protective antigen (rPA) anthrax vaccine -- ... to chemical nerve agents -- RypVax(TM) -- a recombinant dual antigen vaccine for plague a ...

Halozyme Therapeutics Reports 2008 Second Quarter Financial Results

... that combining the Company's proprietary recombinant human hyaluronidase enzyme (rHuPH20) with Humulin ... Investigative Dermatology. HTI-501, a new recombinant human lysosomal proteinase that could provide ... for 30 days. About HYLENEX HYLENEX recombinant (hyaluronidase human injection) is indicated as ...

SemBioSys announces second quarter 2008 financial and operational results

... enter the clinic later this year as the first recombinant human protein produced from safflower to advance ... on the Company's lead pharmaceutical candidates, recombinant human insulin and Apo AI(Milano) and (ii) ... in the plant host safflower, are recombinant human insulin to serve the rapidly expanding ...

SemBioSys submits IND for safflower-produced insulin to U.S. FDA

... New Drug (IND) application for safflower-produced recombinant human insulin to the United States Food and Drug ... of a Phase I/II clinical trial with our recombinant human insulin produced from safflower. All of our ... in the plant host safflower, are recombinant human insulin to serve the rapidly expanding ...

Lilly Reports Solid Second-Quarter Results

... hydrochloride, Lilly) Forteo(R) (teriparatide of recombinant DNA origin injection, Lilly) Gemzar(R) ... Lilly) Humalog(R) (insulin lispro injection of recombinant DNA origin, Lilly) Humulin(R) (human insulin of recombinant DNA origin, Lilly) Strattera(R) (atomoxetine ...

Presentation of North America's First Certificate for BS 25999, the New Standard for Business Continuity

... added. "As the world's leading supplier of recombinant Protein A, we felt that it was important to be on ... -- IT Service Management About Repligen and recombinant Protein A Repligen is the world's leading supplier of recombinant Protein A, a consumable used in the manufacture ...

Deloitte Agrees to Acquire Recombinant Capital, A Leading Life Sciences Subscription Database and Advisory Services Firm

... has announced today an agreement to acquire recombinant Capital, Inc. (Recap), a leading life sciences ... Sciences industry group. "With the addition of recombinant Capital, Deloitte will be uniquely positioned ... future growth plans." "The choice to integrate recombinant Capital and Deloitte merges Recap's unique ...